Temozolomide Capsule
Product Images NDC 72162-2664

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Temozolomide (NDC 72162-2664). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl721622664)

Label (Lbl721622664)
This is a package insert for Temozolomide capsules, each containing 250 mg of the active ingredient. Temozolomide is a cytotoxic drug for oral administration. The recommended storage temperature is 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). It is advised to keep this medication in tight, light-resistant containers and out of reach of children. The insert provides a QR code for detailed usage directions and dosage information, including recommendations on establishing a daily regimen based on varying capsule strengths. The product is manufactured in Turkey, with the relabeling done by Bryant Ranch Prepack, Inc. in Burbank, CA, USA.*
FDA Label Image

Kaplan-meier Curves (Temo Fig2)

Kaplan-meier Curves (Temo Fig2)
This text presents survival data analysis for the ITT population, showing an overall survival benefit with a hazard ratio of 0.63 and a significant P-value of less than 0.0001 based on log-rank test. The time from randomization is shown in months.*
FDA Label Image

Chemical-structure (Temo Structure)

Chemical-structure (Temo Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.